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Abstract
The interaction of reduced nicotinamide mononucleotide (NMNH), constituting one half of NADH, with the wild-type
and KD195E proton-pumping nicotinamide nucleotide transhydrogenase from Escherichia coli was investigated. Reduction
of thio-NADP by NMNH was catalysed at approximately 30% of the rate with NADH. Other activities including proton
pumping and the cyclic reduction of 3P-acetyl-pyridine-NAD by NMNH in the presence of NADP+ were more strongly
inhibited. The KD195 residue is assumed to interact with the 2P-OH moiety of the adenosine-5P-phosphate, i.e., the second
nucleotide of NADH. Mutation of this residue to KD195E resulted in a 90% decrease in activity with NMNH as well as
NADH as substrate, suggesting that it produced global structural changes of the NAD(H) binding site. The results suggest
that the NMN moiety of NADH is a substrate of transhydrogenase, and that the adenine nucleotide is not required for
catalysis or proton pumping. ß 1998 Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Proton-pumping nicotinamide nucleotide transhy-
drogenase catalyzes the reversible reduction of
NADP by NADH linked to the translocation of
one proton (cf. Ref. [1]) according to the reaction
Hout NADHNADP1Hin NAD NADPH
where ‘out’ and ‘in’ denote the periplasmic space and
cytosol, respectively. The enzyme from Escherichia
coli is composed of an K subunit of about 54 kDa
and a L subunit of 48 kDa, and an active form of
K2L2. E. coli transhydrogenase is composed of three
domains, i.e., the hydrophilic domain I (K1^K404)
containing the NAD(H)-binding site, the hydropho-
bic domain II (K405^L260) containing the mem-
brane-spanning K-helices, and the hydrophilic do-
main III (L261^L462) containing the NADP(H)-
binding site (for reviews see Refs. [1^3]).
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At low pH transhydrogenases from E. coli, Rho-
dospirillum rubrum and bovine catalyzes a cyclic re-
action that involves oxidation and reduction of
NADP(H) bound to the NADP(H)-binding site. In
this reaction NADH reduces bound NADP, and
the NAD formed is replaced by AcPyAD which
subsequently is reduced by the bound NADPH. A
similar reaction is catalyzed by the expressed and
puri¢ed domains I and III from both R. rubrum
[4^6].
Based on three-dimensional structures of homo-
logues NAD(H)-dependent dehydrogenases/reduc-
tases, most of the NAD(H)-binding domain I in E.
coli transhydrogenase was recently modelled [7]. This
model identi¢ed this domain as an K/L fold including
the consensus GXGXXG sequence and other resi-
dues involved in binding NAD(H), e.g., KD195 was
assumed to stabilize the 2P-OH moiety of NAD(H)
[7]. In addition, an unusual loop with unknown sec-
ondary structure was identi¢ed between residues
K228 and K250. By nuclear magnetic resonance spec-
troscopy the loop was subsequently demonstrated to
be mobile in the absence but not in the presence of
NAD(H), and it was proposed to function as a lid
that contributed to an increased binding of NADH
[8,9].
The present investigation concerns the nucleotide
speci¢city of the NAD(H)-binding site of E. coli
transhydrogenase. It is shown that the nicotinamide
mononucleotide moiety of NAD(H) is su⁄cient for
catalysis as well as proton pumping although at a
substantially reduced rate.
2. Materials and methods
2.1. Bacterial strains and plasmids
The pnt gene introduced into the constructs
pDC21 or pSA2 was used to transform the E. coli
K12 strain TG1 or JM109, respectively. pDC21 and
pSA2 were employed as a source of wild-type and
mutant transhydrogenases [10,11].
2.2. Mutagenesis
PCR mutagenesis producing the KD195 mutants
was carried out as described [10]. The mutations
were established by complete sequencing.
2.3. Preparation of cytoplasmic membrane vesicles
Inside-out cytoplasmic vesicles were prepared as
described previously [12].
2.4. Puri¢cation of wild-type and mutant E. coli
transhydrogenases
Wild-type and mutant transhydrogenases were pu-
ri¢ed as described [13]. Preparations were at least
90% pure as judged by sodium dodecyl sulfate^poly-
acrylamide gel electrophoresis in the presence of
urea, and stored at 320‡C.
2.5. Activity assays
Catalytic activities of the wild-type and mutant
transhydrogenases, assayed at room temperature ei-
ther with cytoplasmic vesicles or the puri¢ed enzyme,
were determined spectrophotometrically at 375 nm as
reduction of 3-acetyl-NAD (AcPyAD) by
NADPH using a molar absorption coe⁄cient of
5100 M31 cm31. Likewise, the forward reaction
was assayed at 400^460 nm as reduction of thio-
NADP by NADH or nicotinamide mononucleotide
(NMNH) using a molar extinction coe⁄cient of
11 200 M31 cm31 [10,14]. The cyclic reduction of
AcPyAD by NADH in the absence and presence
of NADP was assayed as described [10]. Unless
indicated otherwise, the assay medium for the reverse
reaction contained 20 mM Hepes (pH 7.0), 0.01%
Brij-35, 5 mM MgCl2 ; In the medium for the for-
ward reaction Hepes bu¡er was replaced by 30 mM
MES (pH 6.0). The cyclic reaction was assayed in a
medium containing 25 mM MES^KOH (pH 6.0),
1 mM EDTA, 1 mM DTT and 0.01% Brij-35. Con-
centrations of substrates were routinely 1 mM
AcPyAD, 0.5 mM NADPH, 0.5 mM t-NADP
and 200 WM NADH. In the assay of reduction of
t-NADP by NMNH the concentration of t-NADP
was 200 WM. The cyclic reduction of AcPyAD by
NADH or NMNH was carried out in the presence of
10 WM NADP. NMNH was devoid of NADH as
judged by the lack of e¡ect of pyruvate and lactic
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acid dehydrogenase on the absorbance of NMNH at
340 nm as well as on the rate of reduction of
t-NADP by NMNH by transhydrogenase.
Reconstitution of bacteriorhodopsin-transhydroge-
nase vesicles and the assay for the light (vp)-driven
reduction of NADP by NADH or NMNH was
carried out essentially as described [13].
2.6. Protein determination
Protein was determined by the method of Peterson
[15], using BSA as standard.
2.7. Chemicals
Oligonucleotides were from MedProbe (Oslo, Nor-
way). Enzymes were purchased from Life Technolo-
gies or Boehringer Mannheim. Other biochemicals
were obtained from Sigma or Boehringer Mannheim.
3. Results
The KD195 residue is strongly conserved in
NAD(H)-dependent dehydrogenases/reductases and
is believed to contribute to the stabilization of
NAD(H) bound in the active site through an inter-
action with the 2P-OH group of the adenosine moiety
[7]. Mutagenesis of this residue to N, L, V and E
gave an inactive enzyme (not shown). As shown in
Table 1, only the KD195E mutation, which by most
criteria constitutes a minor change, was partially ac-
tive with a Vm of about 10% of that of the wild-type
enzyme (Table 1). That the KD195E mutation selec-
tively a¡ected only the NAD(H)-binding site was
apparent since the Km;app values for AcPyAD and
NADH were increased 3^5-fold, with virtually no
change in the Km;app for NADPH and t-NADP.
NMN(H) corresponds to NAD(H) minus the ad-
enosine-5P-phosphate nucleotide, and a potential
NMNH-supported activity would therefore not be
expected to be a¡ected by the KD195E mutation to
the same extent as the NADH-supported reaction.
As shown in Fig. 1, NMNH can indeed replace
NADH as hydride donor in the reduction of
t-NADP (forward reaction) catalyzed by puri¢ed
wild-type transhydrogenase from E. coli. Due to
the large light absorption at 400 nm by the millimo-
lar concentrations of NMNH required for activity,
the reaction could not be saturated. However, based
on the concentration dependence of the NMNH-sup-
ported forward reaction up to 4 mM, an approxima-
tion gave that Vm under the conditions used was
about 100 nmol/min per mg protein with a Km;app
of about 6^8 mM. This Vm is more than 30% of
that for the normal forward reaction with NADH
Table 1
Maximal velocities and Km; app of wild-type transhydrogenase and KD195E mutant for AcPyAD, NADPH, NADH and t-NADP
Enzyme Vm (Wmol/min/mg protein) Km; app (WM)
Forward Reverse AcPyAD NADPH NADH t-NADP
Wild-type 1.4 17.5 35.0 15.2 4.90 15.0
KD195E 0.3 1.32 146 17.2 19.0 17.5
Values were derived from double reciprocal plots with at least ¢ve activity determinations at di¡erent substrate concentrations for
each substrate and enzyme.
Fig. 1. Reduction of t-NADP by NMNH catalyzed by wild-
type and KD195E mutant transhydrogenases. The assays were
carried out as described in Section 2. (b) wild-type; (F)
KD195E.
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as substrate, 159 nmol/min per mg protein (cf. Table
1). However, regardless of whether NADH (Table 1)
or NMNH (Fig. 1) was used as hydride donor in the
forward reaction, the KD195E mutation gave a sim-
ilar relative decrease in activity to about 10% of con-
trol. This suggests that the KD195E mutation in-
volves a global change of the NAD(H)-binding site.
Attempts to use NMNH as an inhibitor of the
NADH-dependent forward reaction met with little
success. In the presence of 4 mM NMNH and low
concentrations of NADH, e.g., 5 WM, only a margin-
al inhibition was observed; in addition non-linear
curves were obtained (not shown). Presumably, this
re£ects the poor a⁄nity of NMNH to the NAD(H)-
binding site.
NMNH was also tested as a hydride donor in the
cyclic reduction of AcPyAD by NMNH via bound
NADP(H). As shown in Fig. 2, in the presence of
4 mM NMNH and 10 WM NADP, a cyclic reaction
was indeed obtained in the presence of di¡erent con-
centrations of AcPyAD. However, the dependence
on the concentration of AcPyAD was non-linear, a
phenomenon that presently cannot be explained. The
KD195E mutant showed a similar decrease in the
activity of the cyclic reaction as in the forward reac-
tion (not shown).
An intriguing question is whether NMNH can
support the light-driven reduction of NADP cata-
lyzed by reconstituted bacteriorhodopsin-transhydro-
genase vesicles. A low but signi¢cant 3-fold stimula-
tion by light was observed (not shown). NMN can
also bind to the NADP(H)-site although very poorly.
A very low but signi¢cant activity for the reduction
of NMN by NADPH was found (not shown).
4. Discussion
The present results show that the KD195E mutant
of the KD195 residue still retains approximately 10%
of wild-type activity, whereas the KD195N, KD195L,
KD195V and KD195E mutants were inactive. The
results are consistent with the assumption that
KD195 constitutes part of the NAD(H)-binding
site, with a possible role to stabilize the 2P-OH group
of the adenosine moiety of NAD(H) [7]. Obviously,
the packing of the NAD(H)-binding site in this
region of domain I is extremely tight and sensitive
to minor changes. This is somewhat surprising since
the di¡erence between the two amino acids is only a
^CH2^ group. Nevertheless, the KD195E mutant
displayed a 90% inhibited forward reaction, and a
3^5-fold increased Km;app of the enzyme for NADH
with no change in the Km;app for NADP.
NMN(H) has been used as an NAD-analogue in
the studies of NAD(P)-dependent enzymes [16^20].
Due to the fact that NMN(H) constitutes one half
of the NAD(H) molecule and thus lacks the adeno-
sine moiety that is assumed to interact with the
KD195 residue, it was predicted that the activity of
the wild-type and KD195E mutant enzymes would be
comparable with NMN(H) as substrate. This presup-
poses of course that NMN(H) is a substrate for the
wild-type enzyme, which was suggested on the basis
of inhibitory e¡ects of NMN(H) on the bovine trans-
hydrogenase [20]. When NMNH was used as an in-
hibitor and analogue of NADH, a stimulatory e¡ect
was observed [13]. Indeed, it was shown in the
present investigation that NMNH at millimolar con-
centrations can replace NADH in the forward reac-
tion with only some 30% decrease in activity. How-
ever, when assayed with the cyclic and reverse
reactions as well as proton pumping, NMN(H) re-
placed NAD(H) only poorly. When tested with the
KD195E mutant, however, the inhibition was still
about 90%. This is interpreted to indicate that the
mutation actually caused global changes in the
NAD(H)-binding site.
Fig. 2. Cyclic reduction of AcPyAD by NMNH in the pres-
ence of NADP. Conditions were as described in Section 2.
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The earlier observation that NMNH may not be
only an inhibitor but also a stimulator of, e.g., trans-
hydrogenase-catalysed reduction of t-NADP by
NADH [13] is confusing, but may possibly indicate
that both K subunits in the K2L2 enzyme interact with
NADH/NMNH. Normally, transhydrogenase is be-
lieved to follow a mechanism involving half-of-the-
sites reactivity (cf. Refs. [2,3]). This interesting pos-
sibility is presently being investigated.
Jackson and coworkers [8,9] demonstrated that
part of the NAD(H)-binding site of transhydroge-
nases contains a mobile loop, in the Rhodospirillum
rubrum enzyme in the region K228^K250, the mobi-
lity of which was in£uenced by NAD(H) and adeno-
sine derivatives but not NMN. One role of the loop
may be to create a pocket for an ‘occluded’ substrate
mediated by the adenosine moiety. Obviously, since
NMNH lacks the adenosine moiety, this occlusion
by the loop would not be possible. Therefore, re-
placement of NADH with NMNH provides the
NAD(H)-binding site with a suboptimal substrate
that has a low a⁄nity for the site, as found in this
study. Nevertheless, since NMN(H) was found to be
a substrate for the forward, reverse and cyclic reac-
tions as well as proton pumping, it may be concluded
that the adenosine moiety is not required for these
activities.
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